Functional assessment of human femoral arteries after cryopreservation.
OBJECTIVE
An established method of cryostorage that might preserve the vascular and endothelial responses of human femoral arteries (HFAs) to be transplanted as allografts was studied.


METHODS
HFAs were harvested from multiorgan donors and stored at 4 degrees C in Belzer solution before cryostorage. One hundred eleven HFA rings were isolated and randomly assigned to 1 control group of unfrozen HFAs and 2 groups of HFAs cryopreserved for 7 and 30 days, respectively. Cryopreservation was performed in Elohes solution containing dimethyl sulfoxide (1.8 mmol/L), and the rate of cooling was 1.6 degrees C/min, until -141 degrees C was reached. The contractile and relaxant responses of unfrozen and frozen/thawed arteries were assessed in organ bath by measurement of isometric force generated by the HFAs.


RESULTS
After thawing, the maximal contractile responses to all the contracting agonists tested (KCl, U46619 [a thromboxane A2-mimetic], norepinephrine, serotonin, and endothelin-1) were in the range of 7% to 34% of the responses in unfrozen HFAs. The endothelium-independent relaxant responses to forskolin and verapamil were weakly altered, whereas the endothelium-independent relaxant responses to sodium nitroprusside were markedly reduced. Cryostorage of HFAs also resulted in a loss of the endothelium-dependent relaxant response to acetylcholine. The vascular and endothelial responses were similarly altered in the HFAs cryopreserved for 7 and 30 days.


CONCLUSIONS
The cryopreservation method used provided a limited preservation of HFAs contractility, a good preservation of the endothelium-independent relaxant responses, but no apparent preservation of the endothelium-dependent relaxation. It is possible that further refinements of the cryopreservation protocol, such as a slower rate of cooling and a more controlled stepwise addition of dimethyl sulfoxide, might allow better post-thaw functional recovery of HFAs.
Stanke
F
F
Laboratory of Pharmacology, PCEBM, Faculté de Médecine de Grenoble, and the Blood Transfusion Center, La Tronche, France.
Riebel
D
D
Carmine
S
S
Cracowski
J L
JL
Caron
F
F
Magne
J L
JL
Egelhoffer
H
H
Bessard
G
G
Devillier
P
P
D015925:Cryopreservation; D004730:Endothelium, Vascular / Q000503:physiopathology; D005263:Femoral Artery / Q000503:physiopathology / Q000637:transplantation*; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D009569:Nitric Oxide / Q000502:physiology; D014184:Transplantation, Homologous; D014661:Vasoconstriction / Q000502:physiology*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D014662:Vasoconstrictor Agents; D009569:Nitric Oxide